Iodinated tracers for imaging amyloid plaques in the brain

Area of Science:

• Neuroimaging
• Radiochemistry
• Molecular Biology

Background:

• Alzheimer's disease (AD) is characterized by excessive beta-amyloid (Abeta) plaque deposition in the brain.
• Abeta plaques are considered a key factor in AD pathogenesis.
• Detecting and monitoring Abeta plaques in living patients is crucial for diagnosis and treatment.

Purpose of the Study:

• To develop novel Abeta plaque-specific imaging agents for detecting and monitoring plaque deposition in vivo.
• To identify potential biomarkers for Alzheimer's disease using advanced imaging techniques.

Main Methods:

• Synthesis and evaluation of various iodinated derivatives as single photon emission computed tomography (SPECT) imaging agents.
• Assessment of in vitro binding affinities and in vivo kinetic properties of candidate imaging agents.
• Exploration of thioflavin, imidazo-pyridine, stilbene, and fluorene derivatives for Abeta plaque targeting.

Main Results:

• Thioflavin derivatives showed high in vitro binding but unfavorable in vivo kinetics.
• Imidazo-pyridine derivatives, like IMPY, demonstrated desirable in vivo properties.
• Stilbene and fluorene compounds also exhibited promising in vitro and in vivo characteristics for SPECT imaging.

Conclusions:

• Novel imaging agents, particularly imidazo-pyridine derivatives, show potential for in vivo detection of Abeta plaques in Alzheimer's disease.
• These agents could serve as valuable biomarkers for early diagnosis and disease monitoring.
• Further research is needed to optimize tracers for effective clinical application in Alzheimer's disease.